Revenue
2022
2023
2024
2025
Physiomics plc (PYC)
Price£0.0055Cached quote
Net income
2022
2023
2024
2025
Free cash flow
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | £784,005 | £543,250 | £597,354 | £830,266 |
| Operating expenses | £1.2M | £1.2M | £1.2M | £1.2M |
| Operating income | −£457,791 | −£670,816 | −£573,733 | −£359,114 |
| Operating margin | −58.39% | −123.48% | −96.05% | −43.25% |
| EBITDA | −£448,206 | −£659,771 | −£561,570 | −£347,979 |
| EBITDA margin | −57.17% | −121.45% | −94.01% | −41.91% |
| Net income | −£415,254 | −£609,352 | −£477,257 | −£253,138 |
| Net profit margin | −52.97% | −112.17% | −79.90% | −30.49% |
| Basic EPSper basic share | -£0.00 | -£0.00 | -£0.00 | -£0.00 |
| Diluted EPSper diluted share | -£0.00 | -£0.00 | -£0.00 | -£0.00 |